The protease ADAM17 at the crossroads of disease: revisiting its significance in inflammation, cancer, and beyond
The protease A Disintegrin And Metalloproteinase 17 (ADAM17) plays a central role in the pathophysiology of several diseases. ADAM17 is involved in the cleavage and shedding of at least 80 known membrane-tethered proteins, which subsequently modulate several intracellular signaling pathways, and the...
Gespeichert in:
| Veröffentlicht in: | The FEBS journal 2024-01, Vol.291 (1), p.10-24 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 24 |
|---|---|
| container_issue | 1 |
| container_start_page | 10 |
| container_title | The FEBS journal |
| container_volume | 291 |
| creator | Saad, Mohamed I Jenkins, Brendan J |
| description | The protease A Disintegrin And Metalloproteinase 17 (ADAM17) plays a central role in the pathophysiology of several diseases. ADAM17 is involved in the cleavage and shedding of at least 80 known membrane-tethered proteins, which subsequently modulate several intracellular signaling pathways, and therefore alter cell behavior. Dysregulated expression and/or activation of ADAM17 has been linked to a wide range of autoimmune and inflammatory diseases, cancer, and cardiovascular disease. In this review, we provide an overview of the current state of knowledge from preclinical models and clinical data on the diverse pathophysiological roles of ADAM17, and discuss the mechanisms underlying ADAM17-mediated protein shedding and the potential therapeutic implications of targeting ADAM17 in these diseases. |
| doi_str_mv | 10.1111/febs.16923 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2846929686</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2846929686</sourcerecordid><originalsourceid>FETCH-LOGICAL-c351t-e5cf1d0d114b203f04394fe6afc5a7f737ccb4ed5c0c92f02efea194c0283f153</originalsourceid><addsrcrecordid>eNpdkUtLAzEUhYMoVqsbf4AE3Ih0al7ziLtSn1BxU8HdkMnc1JROpp3MCP33pg-7MFxI7uXjcHMOQleUDGk49wYKP6SJZPwIndFUsEgkcXZ8eIuvHjr3fk4Ij4WUp6jH01iEjpyh1fQb8LKpW1Ae8Ohx9E5TrFrchrFuau-bWpUe1waX1m-YB9zAj_W2tW6GbeuxtzNnjdXKacDWhTILVVWqtbUb4O24GWDlSlzAunblBToxauHhcn_30efz03T8Gk0-Xt7Go0mkeUzbCGJtaElKSkXBCDdEcCkMJMroWKUm5anWhYAy1kRLZggDA4pKoQnLuKEx76PbnW743aoD3-aV9RoWC-Wg7nzOMhEsk0mWBPTmHzqvu8aF7XImiSQsZSIL1N2O2vkCJl82tlLNOqck3wSRb4LIt0EE-Hov2RUVlAf0z3n-Czn1g8s</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2909027248</pqid></control><display><type>article</type><title>The protease ADAM17 at the crossroads of disease: revisiting its significance in inflammation, cancer, and beyond</title><source>Wiley Online Library - AutoHoldings Journals</source><source>MEDLINE</source><creator>Saad, Mohamed I ; Jenkins, Brendan J</creator><creatorcontrib>Saad, Mohamed I ; Jenkins, Brendan J</creatorcontrib><description>The protease A Disintegrin And Metalloproteinase 17 (ADAM17) plays a central role in the pathophysiology of several diseases. ADAM17 is involved in the cleavage and shedding of at least 80 known membrane-tethered proteins, which subsequently modulate several intracellular signaling pathways, and therefore alter cell behavior. Dysregulated expression and/or activation of ADAM17 has been linked to a wide range of autoimmune and inflammatory diseases, cancer, and cardiovascular disease. In this review, we provide an overview of the current state of knowledge from preclinical models and clinical data on the diverse pathophysiological roles of ADAM17, and discuss the mechanisms underlying ADAM17-mediated protein shedding and the potential therapeutic implications of targeting ADAM17 in these diseases.</description><identifier>ISSN: 1742-464X</identifier><identifier>EISSN: 1742-4658</identifier><identifier>DOI: 10.1111/febs.16923</identifier><identifier>PMID: 37540030</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>ADAM protein ; ADAM Proteins - metabolism ; ADAM Proteins - therapeutic use ; ADAM17 Protein - genetics ; ADAM17 Protein - metabolism ; Cancer ; Cardiovascular diseases ; Endopeptidases ; Humans ; Inflammation ; Inflammatory diseases ; Intracellular signalling ; Membrane Proteins - metabolism ; Neoplasms - drug therapy ; Neoplasms - genetics ; Pathophysiology ; Protease ; Proteins ; Shedding</subject><ispartof>The FEBS journal, 2024-01, Vol.291 (1), p.10-24</ispartof><rights>2023 The Authors. The FEBS Journal published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.</rights><rights>2023. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c351t-e5cf1d0d114b203f04394fe6afc5a7f737ccb4ed5c0c92f02efea194c0283f153</citedby><cites>FETCH-LOGICAL-c351t-e5cf1d0d114b203f04394fe6afc5a7f737ccb4ed5c0c92f02efea194c0283f153</cites><orcidid>0000-0002-4855-2360 ; 0000-0002-7552-4656</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37540030$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Saad, Mohamed I</creatorcontrib><creatorcontrib>Jenkins, Brendan J</creatorcontrib><title>The protease ADAM17 at the crossroads of disease: revisiting its significance in inflammation, cancer, and beyond</title><title>The FEBS journal</title><addtitle>FEBS J</addtitle><description>The protease A Disintegrin And Metalloproteinase 17 (ADAM17) plays a central role in the pathophysiology of several diseases. ADAM17 is involved in the cleavage and shedding of at least 80 known membrane-tethered proteins, which subsequently modulate several intracellular signaling pathways, and therefore alter cell behavior. Dysregulated expression and/or activation of ADAM17 has been linked to a wide range of autoimmune and inflammatory diseases, cancer, and cardiovascular disease. In this review, we provide an overview of the current state of knowledge from preclinical models and clinical data on the diverse pathophysiological roles of ADAM17, and discuss the mechanisms underlying ADAM17-mediated protein shedding and the potential therapeutic implications of targeting ADAM17 in these diseases.</description><subject>ADAM protein</subject><subject>ADAM Proteins - metabolism</subject><subject>ADAM Proteins - therapeutic use</subject><subject>ADAM17 Protein - genetics</subject><subject>ADAM17 Protein - metabolism</subject><subject>Cancer</subject><subject>Cardiovascular diseases</subject><subject>Endopeptidases</subject><subject>Humans</subject><subject>Inflammation</subject><subject>Inflammatory diseases</subject><subject>Intracellular signalling</subject><subject>Membrane Proteins - metabolism</subject><subject>Neoplasms - drug therapy</subject><subject>Neoplasms - genetics</subject><subject>Pathophysiology</subject><subject>Protease</subject><subject>Proteins</subject><subject>Shedding</subject><issn>1742-464X</issn><issn>1742-4658</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkUtLAzEUhYMoVqsbf4AE3Ih0al7ziLtSn1BxU8HdkMnc1JROpp3MCP33pg-7MFxI7uXjcHMOQleUDGk49wYKP6SJZPwIndFUsEgkcXZ8eIuvHjr3fk4Ij4WUp6jH01iEjpyh1fQb8LKpW1Ae8Ohx9E5TrFrchrFuau-bWpUe1waX1m-YB9zAj_W2tW6GbeuxtzNnjdXKacDWhTILVVWqtbUb4O24GWDlSlzAunblBToxauHhcn_30efz03T8Gk0-Xt7Go0mkeUzbCGJtaElKSkXBCDdEcCkMJMroWKUm5anWhYAy1kRLZggDA4pKoQnLuKEx76PbnW743aoD3-aV9RoWC-Wg7nzOMhEsk0mWBPTmHzqvu8aF7XImiSQsZSIL1N2O2vkCJl82tlLNOqck3wSRb4LIt0EE-Hov2RUVlAf0z3n-Czn1g8s</recordid><startdate>202401</startdate><enddate>202401</enddate><creator>Saad, Mohamed I</creator><creator>Jenkins, Brendan J</creator><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7TM</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-4855-2360</orcidid><orcidid>https://orcid.org/0000-0002-7552-4656</orcidid></search><sort><creationdate>202401</creationdate><title>The protease ADAM17 at the crossroads of disease: revisiting its significance in inflammation, cancer, and beyond</title><author>Saad, Mohamed I ; Jenkins, Brendan J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c351t-e5cf1d0d114b203f04394fe6afc5a7f737ccb4ed5c0c92f02efea194c0283f153</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>ADAM protein</topic><topic>ADAM Proteins - metabolism</topic><topic>ADAM Proteins - therapeutic use</topic><topic>ADAM17 Protein - genetics</topic><topic>ADAM17 Protein - metabolism</topic><topic>Cancer</topic><topic>Cardiovascular diseases</topic><topic>Endopeptidases</topic><topic>Humans</topic><topic>Inflammation</topic><topic>Inflammatory diseases</topic><topic>Intracellular signalling</topic><topic>Membrane Proteins - metabolism</topic><topic>Neoplasms - drug therapy</topic><topic>Neoplasms - genetics</topic><topic>Pathophysiology</topic><topic>Protease</topic><topic>Proteins</topic><topic>Shedding</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Saad, Mohamed I</creatorcontrib><creatorcontrib>Jenkins, Brendan J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The FEBS journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Saad, Mohamed I</au><au>Jenkins, Brendan J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The protease ADAM17 at the crossroads of disease: revisiting its significance in inflammation, cancer, and beyond</atitle><jtitle>The FEBS journal</jtitle><addtitle>FEBS J</addtitle><date>2024-01</date><risdate>2024</risdate><volume>291</volume><issue>1</issue><spage>10</spage><epage>24</epage><pages>10-24</pages><issn>1742-464X</issn><eissn>1742-4658</eissn><abstract>The protease A Disintegrin And Metalloproteinase 17 (ADAM17) plays a central role in the pathophysiology of several diseases. ADAM17 is involved in the cleavage and shedding of at least 80 known membrane-tethered proteins, which subsequently modulate several intracellular signaling pathways, and therefore alter cell behavior. Dysregulated expression and/or activation of ADAM17 has been linked to a wide range of autoimmune and inflammatory diseases, cancer, and cardiovascular disease. In this review, we provide an overview of the current state of knowledge from preclinical models and clinical data on the diverse pathophysiological roles of ADAM17, and discuss the mechanisms underlying ADAM17-mediated protein shedding and the potential therapeutic implications of targeting ADAM17 in these diseases.</abstract><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>37540030</pmid><doi>10.1111/febs.16923</doi><tpages>15</tpages><orcidid>https://orcid.org/0000-0002-4855-2360</orcidid><orcidid>https://orcid.org/0000-0002-7552-4656</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1742-464X |
| ispartof | The FEBS journal, 2024-01, Vol.291 (1), p.10-24 |
| issn | 1742-464X 1742-4658 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2846929686 |
| source | Wiley Online Library - AutoHoldings Journals; MEDLINE |
| subjects | ADAM protein ADAM Proteins - metabolism ADAM Proteins - therapeutic use ADAM17 Protein - genetics ADAM17 Protein - metabolism Cancer Cardiovascular diseases Endopeptidases Humans Inflammation Inflammatory diseases Intracellular signalling Membrane Proteins - metabolism Neoplasms - drug therapy Neoplasms - genetics Pathophysiology Protease Proteins Shedding |
| title | The protease ADAM17 at the crossroads of disease: revisiting its significance in inflammation, cancer, and beyond |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T03%3A39%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20protease%20ADAM17%20at%20the%20crossroads%20of%20disease:%20revisiting%20its%20significance%20in%20inflammation,%20cancer,%20and%20beyond&rft.jtitle=The%20FEBS%20journal&rft.au=Saad,%20Mohamed%20I&rft.date=2024-01&rft.volume=291&rft.issue=1&rft.spage=10&rft.epage=24&rft.pages=10-24&rft.issn=1742-464X&rft.eissn=1742-4658&rft_id=info:doi/10.1111/febs.16923&rft_dat=%3Cproquest_cross%3E2846929686%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2909027248&rft_id=info:pmid/37540030&rfr_iscdi=true |